View Author
dai: 075064995
scopus: 27167510600
Lubsen, J.
(Jacob Lubsen)Supervisor (promotor) of 3 dissertations
patient study trial infarction death treatment symptom group heart event effect follow-up result inclusion mortality table angina infarct size practice disease therapy infarct analysis number chest pain history diagnosis angiography function difference hospital thrombolytic therapy infusion a.c.e month heart failure point outcome women stroke alteplase streptokinase research criteria baseline artery rotterdam value inclusion criteria thrombolysi method chapter model chest lubsen cause failure ratio enzyme information score randomized action study medication intracoronary thrombolytic control instance population 1 patient procedure infarct-related management medication netherland patienten ejection fraction design stenosi reocclusion
10 Most Recent Publications
|
The future of clinical trials in secondary prevention after acute coronary syndromes
(Article)
Bueno, H. Armstrong, P.W. Steg, P.G. Buxton, M.J. Danchin, N. Lubsen, J. Roland, E. Verheugt, F.W.A. Zalewski, A. Jackson, N.C. Komajda, M. |
2011-07-01
|
|
Long-term impact of secondary preventive treatments in patients with stable angina
(Article)
Voko, Z. Brouwer, S. de Lubsen, J. Danchin, N. Otterstad, J.E. Dunselman, P.H.J.M. Kirwan, B.A. |
2011-05-01
|
|
Subgroup effects despite homogeneous heterogeneity test results
(Article)
Groenwold, R.H.H. Rovers, M.M. Lubsen, J. Heijden, G.J.M.G. van der |
2010-07-19
|
|
Statins and risk of incident diabetes
(Article)
Lubsen, J. |
2010-06-21
|
|
Gender Differences in Cardiac Remodeling and Clinical Outcomes in Chronic Stable Angina Pectoris (from the ACTION Trial)
(Article)
Ky, B. Kirwan, B.A. Brouwer, S. de Lubsen, J. Poole-Wilson, P. Otterstad, J.E. Kimmel, S.E. John, S.M.S. |
2010-04-01
|
|
Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: The ACTION experience
(Article)
Vokó, Z. Danchin, N. Brouwer, S. de Kirwan, B.A. Poole-Wilson, P. Lubsen, J. |
2010-01-07
|
|
Unconventional End Points in Cardiovascular Clinical Trials: Should We Be Moving Away From Morbidity and Mortality?
(Article)
Cohn, J. Cleland, J.G.F. Lubsen, J. Borer, J.S. Steg, P.G. Perelman, M. Zannad, F. |
2009-04-01
|
|
A Propensity-Matched Study of Hypertension and Increased Stroke-Related Hospitalization in Chronic Heart Failure
(Article)
Filippatos, G.S. Adamopoulos, C. Ahmed, A. Sui, X. Love, T.E. Pullicino, P.M. Lubsen, J. Bakris, G. Anker, S.D. Howard, G. Kremastinos, D.T. |
2008-06-15
|
|
Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratios
(Article)
Koller, M.T. Stijnen, Th. Steyerberg, E.W. Lubsen, J. |
2008-04-01
|
|
Quality management of a large randomized double-blind multi-centre trial: The ACTION experience
(Article)
Kirwan, B.A. Lubsen, J. Brouwer, S.d. Dalen, F.J. van Pocock, S.J. Clayton, T.C. Danchin, N. Poole-Wilson, P. |
2008-03-01
|